Detalla, Baby Girl .

HRN: 27-01-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2025
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
04/28/2025
05/05/2025
IV
10mg As LD Then 5mg
Q48H
Candida Prophylaxis
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: